Beijing Sciecure Pharmaceutical Co. Ltd

Beijing Sciecure Pharmaceutical Co., Ltd., established in 2002 and restructured in 2007, has evolved into a global pharmaceutical force. With advanced facilities for ampoules, vials, OSD, lyophilization, LVP, and API, the company adheres to CFDA, US FDA, and EU GMP standards, employing automatic control systems like MES, SCADA, DCS, PLC BMS, etc.

The company's laboratory facilitates seamless project, technology, and site transfers, including formulation development testing. The manufacturing workshop, constructed in 2012 with a significant investment, prioritizes preventing cross-contamination through meticulous separation of personnel and logistics channels, controlled by an advanced access system.

Innovation is central to the company's ethos, driven by a dynamic R&D team of over 100 formulators and analysts working in state-of-the-art R&D centers. The commitment to exploring new frontiers in pharmaceuticals positions Beijing Sciecure as an industry leader, delivering advanced and innovative products. The pharmaceutical-grade facility, GMP-certified and ISO 9001: 2015 certified.

Our laboratory facilities play a pivotal role in our operations. We transfer test methods to and from our laboratory based on approved protocols. Our laboratory is well-equipped to handle all test requirements for project transfer, technology transfer, or site transfer. We also undertake formulation development testing, covering the entire spectrum from laboratory trials to large-scale production. Our manufacturing workshop, located in the eastern part of the factory, was constructed in 2012. It boasts a substantial construction area of approximately 5, 000 square meters, representing a total investment of about 200 million yuan At our workshop, we take stringent measures to prevent cross-contamination. The flow of people and logistics channels at each level of the workshop is meticulously separated. To control personnel access, we utilize an advanced access control system that governs entry into the workshop. Innovation is our heartbeat, and our R&D team forms the creative nucleus that drives it. With over 100 formulators and analysts working in multiple R&D centers, we have created a collaborative environment that fosters groundbreaking ideas and inventive solutions. Our R&D centers are equipped with state-of-the-art technologies, enabling our scientists to push the boundaries of pharmaceutical research. Our scientists excel in a variety of areas, including the development of generics, technology-intensive products that are difficult to manufacture, and Active Pharmaceutical Ingredients (APIs). Their dedication to exploring new frontiers in pharmaceuticals positions us as industry leaders in delivering advanced and innovative products. We deliver what we say. The premium products are made in our pharmaceutical-grade facility with GMP certification service, and most of the tests or verification were done in our laboratory, which was approved by the CNAS level.

Beijing Sciecure boasts approvals from regulatory bodies such as MHRA, US FDA, and CFDA, reflecting a dedication to international standards. An exceptional achievement is the submission of the Technical Product Master File (TPMF) to the US FDA, making them the first and only Chinese pharmaceutical company to receive FDA acceptance (STN: MF0000868). This accomplishment reaffirms their dedication to excellence and regulatory compliance on a global scale.